North Carolina will get a cut of a nationwide opioid settlement. Purdue Pharma and its Sackler family owners agreed to more than $7 billion. It is tied to claims that OxyContin caused a widespread ...

A bipartisan coalition of states has reached a $7.4 billion settlement in principle with members of the Sackler family and their former company Purdue Pharma over their role in the opioid crisis.

The new settlement reopens a path to ending Purdue’s chapter 11 case, the longest and costliest corporate bankruptcy stemming from the U.S. opioid epidemic.

Connecticut has joined a new $7.4 billion settlement agreement with OxyContin maker Purdue Pharma and the Sackler family members who own the company.

Under the deal, the Sackler family members will eventually pay a total of $6.5 billion while Purdue will pay $900 million.

Bankrupt Purdue Pharma LP and members of the billionaire Sackler family agreed to pay $7.4 billion to a group of US states, ...

The U.S. Food and Drug Administration (“FDA”), in partnership with the Department of Justice (“DOJ”), pursued significant and, in some ...

In past years we have discussed how opioid-related enforcement efforts have remained a top federal and state priority (here, ...

Martin Elling, ex-McKinsey partner, pleads guilty to obstructing justice by destroying records related to Purdue Pharma's ...

The Sackler family raised their Purdue Pharma bankruptcy settlement to $6.5 billion and agreed to potential future legal ...

“Today’s guilty plea moves us forward in holding accountable ... influence the investigation into McKinsey’s work with Purdue Pharma, Mr. Elling sought to undermine justice and shield ...